https://www.prnewswire.com/news-releases/dtx-pharma-receives-new-funding-grant-to-advance-rna-based-therapeutic-programs-for-charcot-marie-tooth-cmt-301135672.html
DTx Pharma Receives New Funding Grant to Advance RNA-based Therapeutic Programs for Charcot-Marie Tooth (CMT)
-CMT is a genetic rare disease driven by the duplication of the PMP22 gene-